Humanigen
(OTC) HGEN
Humanigen Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.70M
Net Income (TTM)
$53.30M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
HGEN News
HGEN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Humanigen
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Cameron Durrant, MD, MBA
Website
www.humanigen.comHeadquarters
Short Hills, NJ 07078-2625, US
HGEN Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-27%
Net Income Margin
-28%
Return on Equity
2%
Return on Capital
2%
Return on Assets
-6%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.51M
Operating Income
$68.30M
EBITDA
$67.32M
Operating Cash Flow
$76.70M
Capital Expenditure
$0.00
Free Cash Flow
$76.70M
Cash & ST Invst.
$10.15M
Total Debt
$0.00
Humanigen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$221.00K
-78.7%
Gross Profit
$221.00K
-78.7%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
6
N/A
Net Income
$4.15M
+80.5%
EBITDA
$4.09M
+80.1%
Quarterly Fundamentals
Net Cash
$3.10M
-92.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
N/A
Return on Assets
-6.27%
N/A
Return on Invested Capital
1.52%
N/A
Free Cash Flow
$7.06M
+63.7%
Operating Cash Flow
$7.06M
+63.7%